Replies to post #20852 on Humanigen Inc (fka HGENQ)

[MWM]

LOL $8

[PITrader87]

Please explain, What is your logic? If you were running this company would you sell at that valuation? The company literally just had an underwritten offering at these prices and had additional costs associated with uplisting, why not just sell the whole company before going through all that then?

IMO, There is 0 chance they would sell now (unless presented with a multi-billion $ offer), especially after dumping all this money into trials that are on the verge of completion. If Lenz is approved as a covid therapeutic, there will instantly be enough revenue to sustain the company without further rounds of raising capital. They have manufacturing deals in place and could be weeks away from receiving a EUA from the P3 and BET trials.

They don't HAVE to sell - if the drug is successful in COVID & in it's other applications, this company will be bought for billions by big pharma or it will become big pharma, and, yes, it will rule.

[nelskof]

Oh, so you don't think it's a POS anymore. Got it. I thought you were waiting until $7 to buy back in. (or it would be $5)

Must be my derangement being on this board you talked about.